Theravance News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.09.24	Unveiling 4 Analyst Insights On Theravance Biopharma (Benzinga)
06.08.24	Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma (Benzinga)
26.02.24	Recap: Theravance Biopharma Q4 Earnings (Benzinga)
23.02.24	A Preview Of Theravance Biopharma's Earnings (Benzinga)
05.01.24	Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today? (Benzinga)
05.01.24	Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session (Benzinga)
27.12.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN (PR Newswire)
22.12.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX (PR Newswire)
22.12.23	Theseus Pharma To Acquire Concentra Biosciences For $4.05/Shr In Cash (RTTNews)
27.11.23	Theseus Pharma To Evaluate Expression Of Interest From Foresite, OrbiM And Proposal From Concentra (RTTNews)
14.07.23	Pre-market Movers: ARBB, THRX, LESL, EDTX, LUNR, ACAD… (RTTNews)
13.07.23	Theseus Pharmaceuticals Terminates Development Of THE-630 (RTTNews)
17.12.21	Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies (PR Newswire)
24.09.15	GSK & Theravance To File SJNDA For Relvar Ellipta In Japan - Quick Facts (RTTNews)
08.09.15	GlaxoSmithKline: SUMMIT COPD CV Survival Study Fails To Meet Primary Point (RTTNews)
06.08.15	GSK Gets Canadian Approval For BREO ELLIPTA For Treatment Of Asthma In Adults (RTTNews)
01.05.15	MDCO Gets FDA Nod For 2 Products, EXEL Awaits METEOR Data, WX To Make History (RTTNews)
01.05.15	GSK : FDA Approves BREO ELLIPTA To Treat Adults With Asthma In US (RTTNews)
20.03.15	FOLD Expands, CERU Hits A High, FDA Panel Verdict Out On Breo Ellipta (RTTNews)
20.03.15	FDA Panel Recommends Approval Of GSK Asthma Drug For Adults But Not Adolescents (RTTNews)
24.02.15	BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back (RTTNews)
09.02.15	GSK,Theravance Start Phase III Lung Function Study For COPD - Quick Facts (RTTNews)
31.10.14	Theravance Q3 Loss Sharply Narrows, Approves Dividend - Quick Facts (RTTNews)
10.10.14	Theravance Appoints Eric D'Esparbes As New CFO (RTTNews)
09.10.14	Theravance Appoints Eric D'Esparbes As CFO (RTTNews)
07.08.14	Theravance Q2 Loss Widens (RTTNews)
07.07.14	GlaxoSmithKline: Anoro Ellipta Gets Approval In Japan For Treatment Of COPD (RTTNews)
04.07.14	GSK And Theravance : Anoro Ellipta Gets Approval In Japan For Treatment Of COPD (RTTNews)
30.06.14	GSK And Theravance Announce Submission Of SNDA To FDA For FF/VI In Asthma (RTTNews)
11.06.14	GSK, Theravance Report Positive Data From Two Studies Involving Incruse Ellipta (RTTNews)
28.04.14	Glaxo, Theravance Launches Anoro Ellipta In U.S (RTTNews)
22.04.14	GSK,Theravance Announce Phase III Study Of FF/VI In COPD (RTTNews)
14.03.14	Glaxo, Theravance Reveal Positive Results From 3 Late-stage Studies In COPD (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Theravance Inc.

Aktien Top/Flop

Meistgelesene Nachrichten